{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:55:36Z","timestamp":1790430936156,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.clim.2017.10.002","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T18:19:27Z","timestamp":1507832367000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens"],"prefix":"10.1016","volume":"187","author":[{"given":"Jeff","family":"DeFalco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Harbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Manning-Bog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilson","family":"Baia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Millare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Zuno-Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongkyoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg","family":"Espiritu Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Haaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldar","family":"Giladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Minor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann Chong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B.","family":"Sokolove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2437-2250","authenticated-orcid":false,"given":"Lawrence","family":"Steinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito A.","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Cavet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman M.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Glanville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Volkmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Emerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.10.002_bb0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nm0598-627","article-title":"B cells inhibit induction of T cell-dependent tumor immunity","volume":"4","author":"Qin","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2017.10.002_bb0010","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00262-016-1848-z","article-title":"Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models","volume":"65","author":"Guy","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2017.10.002_bb0015","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2017.10.002_bb0020","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1172\/JCI65579","article-title":"IgG4 subclass antibodies impair antitumor immunity in melanoma","volume":"123","author":"Karagiannis","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.10.002_bb0025","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-07-4782","article-title":"Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity","volume":"14","author":"Sittler","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2017.10.002_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature14424","article-title":"Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity","volume":"521","author":"Carmi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.10.002_bb0035","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.1158\/0008-5472.CAN-10-1852","article-title":"Active immunotherapy induces antibody responses that target tumor angiogenesis","volume":"70","author":"Schoenfeld","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2017.10.002_bb0040","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00262-009-0733-4","article-title":"A systematic review of humoral immune responses against tumor antigens","volume":"58","author":"Reuschenbach","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2017.10.002_bb0045","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1349-7006.2009.01181.x","article-title":"Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers","volume":"100","author":"Shigematsu","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.clim.2017.10.002_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De Silva","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2017.10.002_bb0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2017.10.002_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrrheum.2014.220","article-title":"Sequencing the functional antibody repertoire\u2014diagnostic and therapeutic discovery","volume":"11","author":"Robinson","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2017.10.002_bb0065","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.10.002_bb0070","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1128\/JVI.06075-11","article-title":"Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans","volume":"86","author":"Wrammert","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2017.10.002_bb0075","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/art.38754","article-title":"Barcode-enabled sequencing of plasmablast antibody repertoires in rheumatoid arthritis","volume":"66","author":"Tan","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.10.002_bb0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2017.10.002_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2013.12.008","article-title":"High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination","volume":"151","author":"Tan","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.10.002_bb0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2016.02.022","article-title":"Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody","volume":"165","author":"Bonsignori","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.clim.2017.10.002_bb0095","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.10.002_bb0100","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.10.002_bb0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm.3773","article-title":"High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma","volume":"21","author":"Linnemann","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2017.10.002_bb0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.clim.2017.10.002_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.clim.2017.10.002_bb0120","first-page":"5","article-title":"CTLA-4 blockade in tumor models: an overview of preclinical and translational research","volume":"13","author":"Grosso","year":"2013","journal-title":"Cancer Immun."},{"key":"10.1016\/j.clim.2017.10.002_bb0125","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00262-013-1451-5","article-title":"Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models","volume":"62","author":"Jure-Kunkel","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"issue":"2035","key":"10.1016\/j.clim.2017.10.002_bb0130","article-title":"Abscopal effect in a patient with melanoma","volume":"366","author":"Hiniker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.10.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4925","article-title":"Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4\/PD-1 blockade","volume":"7","author":"Muller","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2017.10.002_bb0140","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.2438","article-title":"Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido","volume":"17","author":"Balachandran","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2017.10.002_bb0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2017.10.002_bb0150","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2017.10.002_bb0155","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1172\/JCI86892","article-title":"The host STING pathway at the interface of cancer and immunity","volume":"126","author":"Corrales","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.10.002_bb0160","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.aaf2288","article-title":"Targeting of cancer neoantigens with donor-derived T cell receptor repertoires","volume":"352","author":"Stronen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.clim.2017.10.002_bb0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature18945","article-title":"Neoantigen landscape dynamics during human melanoma-T cell interactions","volume":"536","author":"Verdegaal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.10.002_bb0170","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm.4051","article-title":"Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients","volume":"22","author":"Gros","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2017.10.002_bb0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","article-title":"Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2017.10.002_bb0180","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fimmu.2015.00531","article-title":"In-depth assessment of within-individual and inter-individual variation in the B cell receptor repertoire","volume":"6","author":"Galson","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2017.10.002_bb0185","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/bioinformatics\/btk004","article-title":"SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations","volume":"22","author":"Volpe","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clim.2017.10.002_bb0190","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.4049\/jimmunol.1201929","article-title":"The restricted DH gene reading frame usage in the expressed human antibody repertoire is selected based upon its amino acid content","volume":"190","author":"Benichou","year":"2013","journal-title":"J. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617305016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617305016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T20:36:33Z","timestamp":1535315793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661617305016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":38,"alternative-id":["S1521661617305016"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.10.002","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}